# Quality Policy - Clinical Outcome Measures Management

| Document ID | POL-001 |
|-------------|---------|
| Title | Quality Policy - Clinical Outcome Measures Management |
| Revision | 1.0 |
| Effective Date | [DATE] |
| Author | [AUTHOR] |
| Approved By | [APPROVER] |

---

## 1. Policy Statement

[ORGANIZATION NAME] is committed to maintaining the highest standards in clinical outcome measure development, validation, implementation, and data management. We ensure that all patient-reported outcomes (PROs), clinician-reported outcomes (ClinROs), observer-reported outcomes (ObsROs), and performance outcomes (PerfOs) used in our research and clinical programs meet rigorous psychometric standards and regulatory requirements.

## 2. Quality Objectives

Our organization commits to:

1. **Scientific Rigor**: Ensuring all outcome measures demonstrate appropriate reliability, validity, responsiveness, and interpretability
2. **Regulatory Compliance**: Maintaining compliance with FDA PRO Guidance, ICH guidelines, and other applicable regulations
3. **Intellectual Property Protection**: Respecting copyright, licensing requirements, and intellectual property rights for all proprietary measures
4. **Cultural Sensitivity**: Ensuring proper translation and linguistic validation for international use
5. **Data Integrity**: Maintaining accurate scoring, data collection, and outcome assessment procedures
6. **Training Excellence**: Ensuring all personnel are appropriately trained and certified in measure administration
7. **Continuous Improvement**: Regularly reviewing and updating measure selection, validation, and implementation procedures

## 3. Management Commitment

Top management demonstrates commitment to clinical outcome measure quality by:

- Ensuring adequate resources for psychometric validation studies
- Supporting proper licensing and intellectual property management
- Promoting evidence-based measure selection aligned with study objectives
- Ensuring translation and linguistic validation follow ISPOR guidelines
- Maintaining separation between clinical care and research assessments where appropriate
- Supporting training and certification programs for measure administrators
- Ensuring electronic clinical outcome assessment (eCOA) systems meet 21 CFR Part 11 requirements
- Engaging with measure developers, copyright holders, and licensing organizations appropriately
- Reviewing measure performance data and validation evidence regularly

## 4. Scope

This policy applies to:
- All clinical outcome measures used in research studies
- Patient-reported, clinician-reported, observer-reported, and performance outcomes
- Psychometric validation activities
- Measure licensing and copyright management
- Translation and linguistic validation projects
- Training and certification of measure administrators
- Electronic and paper-based outcome assessment systems
- Scoring algorithms and data interpretation procedures

## 5. Key Principles

### 5.1 Measure Selection
- Select measures with demonstrated psychometric properties appropriate to the study population and objectives
- Consider respondent burden, literacy requirements, and cultural appropriateness
- Document rationale for measure selection with reference to published validation evidence
- Obtain necessary licenses and permissions before use

### 5.2 Psychometric Validation
- Conduct validation studies following established methodologies (COSMIN, FDA PRO Guidance)
- Document reliability (internal consistency, test-retest, inter-rater)
- Establish validity (content, construct, criterion)
- Assess responsiveness and minimal clinically important difference (MCID)
- Generate normative data or reference values when appropriate

### 5.3 Licensing & Copyright
- Identify and track all proprietary measures requiring licenses
- Maintain current license agreements and ensure compliance with terms
- Track license renewal dates and usage restrictions
- Document copyright attributions and obtain permissions for modifications
- Manage royalty payments for commercial use

### 5.4 Translation & Linguistic Validation
- Follow ISPOR principles of good practice for translation and linguistic validation
- Use forward-backward translation methodology
- Conduct cognitive debriefing with target population
- Obtain linguistic validation certificates
- Maintain version control for all language versions

### 5.5 Training & Certification
- Ensure administrators are trained in measure-specific procedures
- Document training completion and certification status
- Maintain competency through periodic refresher training
- Follow measure developer requirements for administrator qualifications

## 6. Communication

This policy shall be:
- Communicated to all personnel involved in outcome measure activities
- Available to study sponsors, regulatory authorities, and other stakeholders as appropriate
- Reviewed annually for continuing suitability
- Updated to reflect changes in regulatory requirements and scientific best practices

---

## Revision History

| Rev | Date | Description | Author |
|-----|------|-------------|--------|
| 1.0 | [DATE] | Initial release | [AUTHOR] |